Literature DB >> 15287737

Glycosaminoglycan disaccharide alters the dimer dissociation constant of the chemokine MIP-1 beta.

Melissa A McCornack1, Danielle M Boren, Patricia J LiWang.   

Abstract

Chemokines are immune system proteins that recruit and activate leukocytes to sites of infection. This recruitment is believed to involve the establishment of a chemokine concentration gradient by the binding of chemokines to glycosaminoglycans (GAGs). In previous studies, we elucidated the GAG binding site of the chemokine MIP-1beta and implicated the involvement of the chemokine dimer in GAG binding through residues across the dimer interface. In the present studies, nuclear magnetic resonance spectroscopy was used to investigate the effect of GAG binding on MIP-1beta dimerization. Using several dimerization-impaired variants of MIP-1beta (F13Y, F13L, L34W, and L34K), these studies indicate that the addition of disaccharide to the mutants increases their dimerization affinities. For MIP-1beta F13Y, the presence of the disaccharide increases the chemokine dimerization affinity about 9-fold as evidenced by a decrease in the dimer dissociation constant from 610 to 66 microM. Even more dramatically, the dimerization affinity of MIP-1beta L34W also increases upon addition of disaccharide, with the dimer dissociation constant decreasing from 97 to 6.5 microM. After this effect for the mutants of MIP-1beta was shown, similar experiments were conducted with the CC chemokine RANTES, and it was demonstrated that the presence of disaccharide increases its dimerization affinity by almost 7-fold. These findings provide further evidence of the importance of the dimer in chemokine function and provide the first quantitative investigation of the role of GAGs in the manipulation of the MIP-1beta quaternary structure.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15287737     DOI: 10.1021/bi049751u

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  Recognition of a CXCR4 sulfotyrosine by the chemokine stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12).

Authors:  Christopher T Veldkamp; Christoph Seibert; Francis C Peterson; Thomas P Sakmar; Brian F Volkman
Journal:  J Mol Biol       Date:  2006-05-11       Impact factor: 5.469

Review 2.  Rational design of novel HIV-1 entry inhibitors by RANTES engineering.

Authors:  Luca Vangelista; Massimiliano Secchi; Paolo Lusso
Journal:  Vaccine       Date:  2008-01-10       Impact factor: 3.641

3.  Probing receptor binding activity of interleukin-8 dimer using a disulfide trap.

Authors:  Krishna Rajarathnam; Gregory N Prado; Harshica Fernando; Ian Clark-Lewis; Javier Navarro
Journal:  Biochemistry       Date:  2006-06-27       Impact factor: 3.162

4.  Characterization of the interactions of vMIP-II, and a dimeric variant of vMIP-II, with glycosaminoglycans.

Authors:  Bo Zhao; Patricia J Liwang
Journal:  Biochemistry       Date:  2010-08-24       Impact factor: 3.162

5.  The monomer-dimer equilibrium of stromal cell-derived factor-1 (CXCL 12) is altered by pH, phosphate, sulfate, and heparin.

Authors:  Christopher T Veldkamp; Francis C Peterson; Adam J Pelzek; Brian F Volkman
Journal:  Protein Sci       Date:  2005-03-01       Impact factor: 6.725

6.  Molecular basis of glycosaminoglycan heparin binding to the chemokine CXCL1 dimer.

Authors:  Krishna Mohan Poluri; Prem Raj B Joseph; Kirti V Sawant; Krishna Rajarathnam
Journal:  J Biol Chem       Date:  2013-07-17       Impact factor: 5.157

7.  Structural and functional studies of the potent anti-HIV chemokine variant P2-RANTES.

Authors:  Hongjun Jin; Ioannis Kagiampakis; Pingwei Li; Patricia J Liwang
Journal:  Proteins       Date:  2010-02-01

Review 8.  Targeting Chemokine-Glycosaminoglycan Interactions to Inhibit Inflammation.

Authors:  Helena Crijns; Vincent Vanheule; Paul Proost
Journal:  Front Immunol       Date:  2020-03-31       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.